CSMIX
Price
$49.25
Change
-$0.28 (-0.57%)
Updated
Jun 10 closing price
Net Assets
2.34B
SSGSX
Price
$51.33
Change
-$0.51 (-0.98%)
Updated
Jun 10 closing price
Net Assets
4.62B
Interact to see
Advertisement

CSMIX vs SSGSX

Header iconCSMIX vs SSGSX Comparison
Open Charts CSMIX vs SSGSXBanner chart's image
CSMIX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
CSMIX vs. SSGSX commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSMIX is a Hold and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.62B vs. CSMIX (2.34B). CSMIX pays higher dividends than SSGSX: CSMIX (1.85) vs SSGSX (0.54). CSMIX was incepted earlier than SSGSX: CSMIX (40 years) vs SSGSX (27 years). CSMIX (1.23) and SSGSX (1.23) have similar cost to investors . CSMIX is a more actively managed with annual turnover of: 72.00 vs. SSGSX (50.00). CSMIX (6%) and SSGSX (6%) have equivalent initial investment costs. CSMIX has a lower initial minimum investment than SSGSX: CSMIX (2000) vs SSGSX (2500). CSMIX (19.32) and SSGSX (19.32) have marching annual gain over last year. CSMIX return over 5 years is better than : -0.83 vs. SSGSX (-6.85).
CSMIXSSGSXCSMIX / SSGSX
Total Expense Ratio1.201.2398%
Annual Report Gross Expense Ratio1.231.23100%
Fund Existence40 years27 years-
Gain YTD14.23015.99989%
Front Load6%6%100%
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets2.34B4.62B51%
Annual Yield % from dividends1.850.54342%
Returns for 1 year19.3219.32100%
Returns for 3 years26.6012.73209%
Returns for 5 years-0.83-6.8512%
Returns for 10 years37.0040.9090%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BALY15.350.42
+2.81%
Bally's Corporation
TSEM233.645.56
+2.44%
Tower Semiconductor Ltd
APRE0.750.02
+2.22%
Aprea Therapeutics
FNWD33.750.62
+1.87%
Finward Bancorp
ARCB165.16-8.06
-4.65%
ArcBest Corp